Intraperitoneal Cancer Therapy [electronic resource] /edited by C. William Helm, Robert P. Edwards.
by William Helm, C [editor.]; Edwards, Robert P [editor.]; SpringerLink (Online service).
Material type:
Item type | Current location | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|
MAIN LIBRARY | RC254-282 (Browse shelf) | Available |
Browsing MAIN LIBRARY Shelves Close shelf browser
RC254-282 High-Grade Gliomas | RE1-994 Retinal Degenerations | RC648-665.2 Insulin Resistance | RC254-282 Intraperitoneal Cancer Therapy | RM1-950 Opiate Receptors and Antagonists | QH573-671 Apoptosis, Cell Signaling, and Human Diseases | QH573-671 Apoptosis, Cell Signaling, and Human Diseases |
Management of Ovarian Cancer: The Theory -- Management of Ovarian Cancer: Clinical Trials -- A Systematic Review and Meta-Analysis of Randomized Trials -- Immunobiology and Intraperitoneal Immunobiologics in Ovarian Cancer -- Intraperitoneal Chemotherapy: Technique and Complications -- Hyperthermia and Chemotherapy: The Science -- Hyperthermic Intraperitoneal Chemotherapy in Nongynecologic Cancers -- Peritoneal Carcinomatosis of Colorectal Origin -- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer: Experience in France -- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Ovarian Cancer: World Experience -- Techniques of Delivering Hyperthermic Intraperitoneal Chemotherapy -- Future Directions in the Delivery of Hyperthermic Intraperitoneal Chemotherapy.
Intraperitoneal Cancer Therapy investigates intraperitoneal chemotherapy in a variety of complex and interesting ways. The volume details major clinical trails to date, including immunotherapy, hyperthermic treatment of colo-rectal and ovarian cancers. Authors also examine regional approaches to therapy, systemic therapy, and the use of carboplatin and paclitaxel as the standard treatment for women with stages III and IV ovarian cancer. Other chapters also investigate techniques and procedures in treatment, as well as the future direction of both normothermic and hyperthermic intraperitoneal chemotherapy.
There are no comments for this item.